Back
Nektar Therapeutics Vs. Avid Bioservices Industry Stock Comparison
Sell
46
NKTR
Nektar Therapeutics
Last Price:
1.80
Seasonality Move:
-3.09%
Buy
65
CDMO
Avid Bioservices
Last Price:
9.20
Seasonality Move:
10.67%
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.83. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Avid Bioservices (CDMO)
is a Buy
Is Avid Bioservices a Buy, Sell or Hold?
- The current Avid Bioservices [CDMO] share price is $9.25. The Score for CDMO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CDMO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
CDMO Stock Price Chart
What is Avid Bioservices's stock price today?
-
The Avid Bioservices share price today is $9.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDMO is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 66.94 | Buy |
| Chaikin Money Flow: | 638017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.37 - 1.69) | Buy |
| Bollinger Bands (100): | (0.54 - 1.34) | Buy |
CDMO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 71.69 | Buy |
| Chaikin Money Flow: | -763190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.75 - 8.53) | Buy |
| Bollinger Bands (100): | (6.24 - 7.82) | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Buy |
| 20-day SMA: | 1.54 | Buy |
| 50-day SMA: | 1.26 | Buy |
| 200-day SMA: | 0.76 | Buy |
| 8-day EMA: | 1.71 | Buy |
| 20-day EMA: | 1.57 | Buy |
| 50-day EMA: | 1.31 | Buy |
| 200-day EMA: | 1.05 | Buy |
CDMO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.7 | Buy |
| 20-day SMA: | 7.82 | Buy |
| 50-day SMA: | 7.17 | Buy |
| 200-day SMA: | 7.8 | Buy |
| 8-day EMA: | 8.71 | Buy |
| 20-day EMA: | 8.09 | Buy |
| 50-day EMA: | 7.5 | Buy |
| 200-day EMA: | 8.52 | Buy |
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.21 per share.
Avid Bioservices Earnings Growth & CDMO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.41 per share, and an increase next year of $0.12 per share.
Nektar Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avid Bioservices Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||